Dr John Lennert Rigg, MD | |
300 E. Hospital Rd. Dwight D. Eisenhower Building, Neuroscience And Rehabilitation Center 12 East, Fort Gordon Augusta, GA 30905 | |
(706) 787-1273 | |
Not Available |
Full Name | Dr John Lennert Rigg |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 300 E. Hospital Rd. Dwight D. Eisenhower Building, Fort Gordon Augusta, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437124427 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 057996 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Lennert Rigg, MD 504 Creekstone Trail, Evans, GA 30809 Ph: (706) 787-1273 | Dr John Lennert Rigg, MD 300 E. Hospital Rd. Dwight D. Eisenhower Building, Neuroscience And Rehabilitation Center 12 East, Fort Gordon Augusta, GA 30905 Ph: (706) 787-1273 |
News Archive
The gene and hormone soup that enables women to breastfeed their newborns also can be a recipe for breast cancer, particularly when the first pregnancy is after age 30.
Avivia Health announces Avivia Select, a new series of affordable Disease Management and Wellness programs specifically designed to help companies provide important new benefits to their employees. Avivia Health is the only national provider of Disease Management and Wellness Solutions based on 60 years of evidence-based care by parent organization Kaiser Permanente.
Biomerix Corporation announced today that it has received CE Mark approval for its REVIVEā¢ soft tissue repair mesh allowing for the marketing of REVIVE in all European Union member (EU) states. REVIVE received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2009.
Tenet Healthcare Corporation (NYSE: THC) today announced revisions to its outlook for 2009 Adjusted EBITDA to a new range of $900 million to $950 million. The prior outlook range was $810 million to $875 million. This new range corresponds to an outlook for net income attributable to shareholders in a range of $76 million to $141 million. Adjusted EBITDA is a non-GAAP term defined and reconciled to GAAP net income below.
In this study published by the Centers for Medicare & Medicaid Services, researchers analyzed the 1997 Children's Health Insurance Program to evaluate the potential changes in physicians' work hours in response to a large expansion in coverage.
› Verified 2 days ago